MATW · Matthews International Corp · Insider Trading

Award of restricted share units under the Company's Amended and Restated 2017 Equity Incentive Plan (the "Plan"), subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive shares of the Company's common stock as described below.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $23.12, which represents the average of the high and low trading prices per share of the Issuer's Class A common stock on the Nasdaq Global Select Market for the 20 days of trading that immediately preceded the date of issuance.

The award is expected to vest on August 31, 2027 subject to the Reporting Person's continued service to the Issuer through such date, at which point the restricted share units will be converted to an equal number of shares of the Issuer's Class A common stock.

This report does not reflect shares held by an exempt section 501(c)(3) charitable trust for which the reporting person serves as trustee as the Reporting Person holds no pecuniary interest in the shares owned by the charitable trust.

This report is being filed solely to reflect the reporting person's appointment as a trustee with respect to a trust of which he is also a beneficiary. The reporting person may be deemed to share voting and dispositive power with regard to the reported shares held therein. The reporting person disclaims beneficial ownership of the reported shares held by the trust, except to the extent, if any, of his pecuniary interest therein.

On May 14, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On May 14, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

This report does not reflect shares held by an exempt section 501(c)(3) charitable trust for which the reporting person serves as trustee as the Reporting Person holds no pecuniary interest in the shares owned by the charitable trust.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

Award of restricted share units made under the Second Amended and Restated 2019 Director Fee Plan subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive one share of the Company's Class A common stock.

The number of restricted share units issued by the Issuer to the Reporting Person was calculated based on $25.23, which represents the mean of the highest and lowest sales prices per share of the Issuer's Class A common stock on the Nasdaq Exchange on the date of issuance.

The award generally vests on March 12, 2028 at which point the units will be converted to an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

On March 7, 2026, the vesting date, the time-based restricted share units converted into an equal number of shares of the Company's Class A common stock.

Award of restricted share units under the Company's Amended and Restated 2017 Equity Incentive Plan (the "Plan"), subject to the agreement entered into under the Plan. Each restricted share unit represents a contingent right to receive shares of the Company's common stock as described below.

In general, 40% of the grant vests on November 17, 2028; 30% of the grant vests at target based upon the Company achieving certain metrics based on Return on Invested Capital ("ROIC"); and 30% of the grant vests at target based upon stock price appreciation for the Company's common stock. Vesting of all units are generally subject to continuing employment through November 17, 2028. Upon vesting, time-based units will be converted to an equal number of shares of the Company's common stock; performance based units will be converted to the Company's common stock using a factor ranging from 50% to 200% based upon the level of achievement of the performance thresholds related to the above targets. Performance related units that do not achieve the ROIC or stock price appreciation thresholds by the end of the performance period will be forfeited.

Each Deferred Stock Unit ("DSU") is the economic equivalent of one share of Class A common stock. The DSUs become payable in common stock in accordance with a deferral election made by the reporting person or pursuant to the Issuer's Amended and Restated 2019 Director Fee Plan. A copy of such deferral election is on file with the Issuer.

DSUs were issued by the Issuer to the Reporting Person pursuant to dividend equivalent rights.

Sale of shares to the registrant to cover tax withholding on the vesting of restricted share units.

Sale of shares to the registrant to cover tax withholding on the vesting of restricted share units.

Sale of shares to the registrant to cover tax withholding on the vesting of restricted share units.

Sale of shares to the registrant to cover tax withholding on the vesting of restricted share units.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

Sale of shares to the registrant to cover tax withholding on the vesting of restricted share units.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.

On November 20, 2025, the vesting date, the return on invested capital performance-based restricted share units converted into shares of the Company's Class A common stock at a rate of 200%.